Market Entry and Revenue Growth Strategy
Both MedTech and pharmaceutical companies have relied on our analysis to make decisions on tapping into revenue pockets, entering new markets.
Our analysis involves extensive in-depth interviews with key stakeholders including physicians, purchasing managers, CEOs of hospitals and allied healthcare professionals. We also utilize our extensive industry network to gather insights from senior CXO-level industry professionals with deep experience in those markets.
|Client||Multi-billion Dollar pharmaceutical conglomerate looking to deepen presence in Europe|
|Situation||Client, a global player in oncology specialty pharmaceuticals, wanted to broaden its presence in Western Europe and to increase sales|
|Our approach||We mapped EU4+UK as priority markets and conducted deep dive into
We recommended a clear strategy per country along with prioritization. Our recommendations included resource allocation, budgets required, sales to be expected and 5 years business plan per country, along with list of top 10 target accounts per country
|Results||Client was successful in getting board approval for aggressive entry into Europe. In a span of two years following our engagement, client gained significant market share which led them to invest further by setting up a manufacturing facility in Germany to further grow their business in Europe|